Peer Review History
| Original SubmissionMarch 3, 2020 |
|---|
|
PONE-D-20-06207 Quality of clinical assessment and management of sick children by Health Extension Workers in four regions of Ethiopia: a cross-sectional survey PLOS ONE Dear Dr. Daka, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 19 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Elizeus Rutebemberwa Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. In addition, please provide details of the pilot testing of this questionnaire, including the number of participants and where they were recruited from. 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Overall comments 1. This is an excellent and important, needed study. I recommend its publication and suggest only minor revisions. 2. I think the conclusion in lines 452-455 is a dangerous overstatement. Of course, taking away the management role from HEWs is a theoretical possibility and having them refer all sick children to a higher facility with higher-level workers. But is this feasible, especially in Ethiopia where the next level of care is a 3-4-hour walk away and transport is not available? And what is the evidence that higher-level workers trained in iCCM perform better? I am not opposed to keeping this in the paper. However, the real message – at least from my standpoint – is to strengthen supervision and retraining. I think it would be important to investigate whether the supervisors have had training in iCCM and how well they supervise HEW performance in this area. Maybe the MOH should consider having a special cadre of iCCM supervisors who do nothing but provide ongoing training and supervision on this one aspect of the HEWs’ work. 3. There is a need to better document to contribution of stockouts to lack of adherence to guidelines. Of course, better logistical support is an obvious need as well. Questions/issues that I think should be addressed 1. How were the 52 districts selected? 2. On p. 6, lines 151-2: malnutrition, anemia, HIV and immunization/vitamin A status are not symptoms. How anemia and HIV status are determined might be explained. Malnutrition is assessed by MUAC, of course, and immunization/vit A status were presumable assessed by asking the caretaker. 3. How was the community mobilization to get children to attend the health posts carried out? 4. It would be important to document if possible when the iCCM training was provided and what kind of in-service refresher training had been provided. It would also be important to know if the supervisors of the HEWs had been trained in iCCM since then? The findings suggest that this might be one practical implication of the study findings – along with more frequent in-service training on iCCM or perhaps have HEWs go through the entire training again from time to time. After all, recertification is a common requirement for many trainings in the US (cardiopulmonary resuscitation, specialty boards, etc.). What is the evidence from other studies about the “decay rate” in knowledge and practices for CHWs after iCCM? Is there any? 5. How often were drug stockouts present? 6. What are the criteria for RDT testing? Are these contextually appropriate? Should all children with fever have had an RDT for malaria? 7. Were Ready-to-Use Therapeutic Foods actually available at the health post? 8. Don’t HEWs also treat sick children out in the home and in the community? You might at least want to mention that. 9. The paper should at least mention all of the various tasks and roles that HEWs perform beyond iCCM. Minor suggestions for revisions 1. The “v” in vitamin A (line 122, p. 6) should not be capitalized 2. The designation for HEWs is not consistent through the paper: sometimes it is “Health extension worker,” sometimes “health extensions worker,” sometimes “HEW.” 3. Did the observer also count the respiratory rate? How accurately did HEWs accurately count AND CLASSIFY the respiratory rate? Additional minor comments 1. It would be interesting to know if the 9% of HEWs observed who had not received training in iCCM performed as well as those who had been. 2. An interesting follow-up study would be to talk with CHWs about why they did not follow the iCCM guidelines – was it truly a lack of knowledge or other not readily apparent (to the researcher) other complicating factor? 3. P. 20, line 442, should be “workers’ ” not “workers” Reviewer #2: • The authors have written a paper which provides an important perspective on understanding the quality of care provided by health extension workers, and considerations for improving the care quality gap. While these results could add to the body of literature on understanding and strengthening quality in hard-to-reach settings, it requires revisions and clarification of the relationship to the broader study and how this was related to an earlier publication which compared technical quality with a re-exam of the patient. The submission needs changes to improve the clarity of writing and particularly in the methods, and results and discussion detailed below. The manuscript also needs a careful review for grammar and formatting and would consider a copy-editor before resubmission; the manuscript contains multiple typos (for example, lines 62, 198), or unclear or wordy sentences (e.g., 114; 128; 135 – inconsistent capitalization/acronym usage for HEW Major and minor comments. • It is unclear how these findings fit into the overall "Optimizing Health Extension Program" interventions (those which you've listed do not seem directly related to this project), and the trial registration number you've given does not mention OHEP. • The relationship to this study and published results also needs clarification. You refer to another "recent study, based on the same larger survey as this article, [which] showed that the health extension workers’ diagnostic accuracy was low" (ref 17) which included gold standard as re-exam, yet this paper only described observation with a checklist. Why were data from the re-exam not used? For assessments, what were the differences between observation and re-exam? • This manuscript as "part of a larger baseline" survey, but you later say that you calculated power to "correctly assess, classify and treat diseases at baseline vs endline surveys, in intervention and comparison areas." (line 147) and use of a re-exam. Please clarify • Minor: You state that "no previous study has analyzed the entire process of managing sick children at Ethiopian health posts" (line 95), but this is only related to IMCI and children 2months-5 years. This sentence should include these caveats. on describing the symptoms most commonly presented to health posts. Methods • The selection and recruitment processes are unclear and should be consolidated. In line 127, you state "participants were invited," but earlier you state that children who showed up at the health facility were included. The paper later states that community mobilization targeted sick children to have them brought to the facility – which children were targeted and why, and how did community mobilization work? You also state that children "brought to the health post by their caregivers and the health extension workers were eligible" (137) – did HEWs select children for the study in the community and then bring them to the facility? • In line 140, you aimed for an average of 4 sick children per health post – was that a target, or a cap, or a minimum, and what efforts were made to include 4 children? How were the children included selected (who determined they had IMCI-eligible symptoms). Were extremely sick children excluded to not delay referral if needed with the re-exam? The statement "this implies that the sample was not randomly selected to represent the regions"? (359-360). Explanation for the lower number included (620 versus 800) should be explained and if entire health posts were not included (beyond ones excluded for security). Were the final regional distribution of children (Table 1) as planned? • How were HEWs selected? If there are two HEWs at the health facility, who conducted the consultation and how was that decided? Were any HEWs excluded for any reason? • You report that data were collected through a structured observation checklist on tablets (160), but earlier state that "re-examiners" (146) were considered the gold standard. Did re-examination occur? If not, how did you determine whether there was a misdiagnosis? (181) The checklist should be included as well as how they determined if specific actions such as counting breaths were determined. If a child had more than one eligible complaint, were both included? • Who are the trained supervisors (166)? What was their role and how was it different from the data collectors? • What kind of data quality checks occurred and what were the results? • The description of power calculation is unclear (142-147) – it states that the study was powered to "correctly assess, classify and treat diseases at baseline vs endline surveys, in intervention and comparison areas" (148) –. In line 149, you then state that the "study was powered to "ascertain prevalence (for example when performing a certain assessment)" – prevalence of what?. Finally, if only 620 children ultimately included how did the power increased from 80% to 85%? Ethics • It is important to note if there any considerations for delay of care for severely ill children if gold standard re-review was included (see questions above) • How was consent gathered form non-biological parents? (187) • Were children who required urgent referral but were not referred by HEWs referred by the supervisor or data collector (312)? • Results and Discussion • Throughout, please make it clear what is the standard of care. For example – are HEWs expected to ask about all three general danger signs (line 224), assess for chest-indrawing (225), examine for meningitis in fever cases (273) and when are they supposed to prescribe antibiotics for all cases? (237, 291)? The comparison to protocols is done better in the MUAC section (293), where you describe the expectations for HEWs as compared to their performance, although you do not mention whether correctness of MUAC procedure is assessed. While many readers may be familiar with IMCI, they may differ by country. Consider a table as a supplement • I was confused by the data on fast breathing. For example, in line 228-231, You report that HEWs counted fast breathing in 74% of cases and only correctly labeled fast breathing in 78% of cases with fast breathing. How was that confirmed Especially if the HEW did not perform the exam? • Line 201: you note that only 91% of sick child consultations were done by HEWs – who conducted the other 9%? If the study was to evaluate HEWs were these excluded? Same question for non-IMCI conditions (ex. Burns) • Line 215: please clarify how were symptoms assessed? It is unclear if it is from caregiver report, examination, re-examination, or some other data collector assessment. For example – in line 215, was fever just based on complaint, evaluation by the HEW, use of thermometer, etc.? • In limitations, I was not sure that I understand the statement line 360 you can have “no reason to believe” children represented the rural areas in the 4 regions. Can the authors add in a reference for example about the range of conditions and severity being “as expected”. Also typically limitations are towards the end of the discussions, not in the middle • Understanding variability across regions would be important and consider as well a metric of overall quality per HEWs (for those with >1 observation-were there higher and lower performers or did they all provide similar overall quality (or challenges)? • The discussion brings in data from other studies. A brief discussion why some results differ in this study is important. In addition, please include actual numbers (line 393 described the Tanzania results as more optimal. • I was confused by the statement line 389 that the study was “performed when the management program was fully scaled up”-the timing of this assessment and if baseline or endline needs clarification. • The statement starting line 440 was confusing and needs clarification Tables and Figures • While I appreciate the details in the figures flow diagrams, it is hard to look across tasks and diseases and without %, hard to determine rates. It would be better to present tables of the results of HEW performance in addition to the table on counseling, as the reader gets a bit lost in the text. Table 1 could be described an in a supplement if you need more space. Minor comments • 25 – In your abstract, you state that low care seeking may be due to unfavorable community perceptions of quality of care provided, but you do not support with references or other with evidence in the manuscript. • 68 – Please clarify whether 37,000 HEWs have been deployed over the history of the program, or are 27,000 HEWs currently deployed? • 249 – How is labelling by an HEW as not visibly awake different than assessing for unconsciousness? • 233-235 – Include percent along with number of children. • 251 –What does "examined the presence of dehydration" mean – is that through physical exam? Was the appropriateness/accuracy of the exam evaluated? • 365 – How do you know what the expected mix of complaints would be? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Henry B. Perry Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Quality of clinical assessment and management of sick children by Health Extension Workers in four regions of Ethiopia: a cross-sectional survey PONE-D-20-06207R1 Dear Dr. Daka, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Elizeus Rutebemberwa Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I have read all of the responses to the comments of the reviewers. I think the changes made in the manuscript appropriately respond to the concerns of the reviewers. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Henry B. Perry |
| Formally Accepted |
|
PONE-D-20-06207R1 Quality of clinical assessment and management of sick children by Health Extension Workers in four regions of Ethiopia: a cross-sectional survey Dear Dr. Daka: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Elizeus Rutebemberwa Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .